MedPath

Primidone

Primidone Tablets, USP Anticonvulsant

Approved
Approval ID

3e081b24-20f5-4ffd-b493-771fd4ac2c96

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 2, 2018

Manufacturers
FDA

Aphena Pharma Solutions - Tennessee, LLC

DUNS: 128385585

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

primidone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71610-079
Application NumberANDA040586
Product Classification
M
Marketing Category
C73584
G
Generic Name
primidone
Product Specifications
Route of AdministrationORAL
Effective DateJuly 2, 2018
FDA Product Classification

INGREDIENTS (8)

CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
PRIMIDONEActive
Quantity: 50 mg in 1 1
Code: 13AFD7670Q
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Primidone - FDA Drug Approval Details